Paper
0
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study
Authors
Robert Coleman,Domenica Lorusso
Christine Gennigens,Antonio González-Martı́n,Leslie Randall,David Cibula,Bente Lund,Linn Woelber,Sandro Pignata,Frédéric Forget,Andrés Redondo,Signe Vindeløv,Menghui Chen,Jeffrey Harris,Margaret Smith,Leonardo Nicacio,Melinda Teng,Annouschka Laenen,Reshma Rangwala,Luís Manso,Mansoor Mirza,Bradley Monk,Ignace Vergote,Francesco Raspagliesi,Bohuslav Melichar,Lydia Garcia,Amanda Jackson,Stéphanie Henry,Zdeněk Král,Philipp Harter,Ugo Giorgi,Maria Bjurberg,Michael Gold,David O’Malley,Brigitte Honhon,Christof Vulsteke,Eveline Cuypere,Hannelore Denys,Jean‐François Baurain,Claudio Zamagni,Meaghan Tenney,Mary Gordinier,William Bradley,Matthew Schlumbrecht,Nicola Spirtos,Nicole Concin,Sven Mahner,Giovanni Scambia,Charles Leath,Robin Farias‐Eisner,Joshua Cohen,Carolyn Muller,Sumeet Bhatia,W. Bradley
+52 authors
,Antonio González‐MartínJournal
Published
Apr 9, 2021
Show more
Save
Tip0
TipSave